Introduction In light of the increasing number of economic burden studies and heterogeneity
in methodology and reporting standards, there is a need for robust evidence synthesis on an …

The purpose of this article is to provide a critical evaluation of the available literature
describing the economic burden of multiple sclerosis and to assess the gaps in information …

Background Cost-of-illness (COI) studies of Multiple Sclerosis (MS) are vital components for
describing the economic burden of MS, and are frequently used in model studies of …

OBJECTIVE: To derive robust estimates for the cost of multiple sclerosis (MS) based on a
variety of cost factors across a number of different cost perspectives. This is essential to …

BACKGROUND: Multiple sclerosis (MS) is chronic progressive disease that poses a
significant economic burden to patients and health care systems in the United States. We …

Objectives: To estimate average annual cost per multiple sclerosis (MS) patient in the US
using published estimates from the literature. Methods: A search was performed of English …

Health outcome studies constitute a new and emerging field of multiple sclerosis research.
All studies performed so far underscore the importance of indirect cost in multiple sclerosis …

Multiple sclerosis (MS) is a disease of the CNS, typically striking adults during the primary
productive time of their life. The symptoms of MS can restrict the individual's physical activity …

Background Although the economic burden of multiple sclerosis (MS) in high-income
countries (HICs) has been extensively studied, information on the costs of MS in low-and …

Background Multiple sclerosis has both high healthcare and social impacts. Objective The
purpose of this article is to analyse the available literature describing the economic burden …